Author:
Murrell Dedee F.,Daniel Benjamin S.,Joly Pascal,Borradori Luca,Amagai Masayuki,Hashimoto Takashi,Caux Frdric,Marinovic Branka,Sinha Animesh A.,Hertl Michael,Bernard Philippe,Sirois David,Cianchini Giuseppe,Fairley Janet A.,Jonkman Marcel F.,Pandya Amit G.,Rubenstein David,Zillikens Detlef,Payne Aimee S.,Woodley David,Zambruno Giovanna,Aoki Valeria,Pincelli Carlo,Diaz Luis,Hall Russell P.,Meurer Michael,Mascaro Jose M.,Schmidt Enno,Shimizu Hiroshi,Zone John,Swerlick Robert,Mimouni Daniel,Culton Donna,Lipozencic Jasna,Bince Benjamin,Grando Sergei A.,Bystryn Jean-Claude,Werth Victoria P.
Reference10 articles.
1. Interventions for bullous pemphigoid;Kirtschig;Cochrane Database Syst Rev,2010
2. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus;Murrell;J Am Acad Dermatol,2008
3. Reliability and convergent validity of two outcome instruments for pemphigus;Rosenbach;J Invest Dermatol,2009
4. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus;Pfutze;Eur J Dermatol,2007
5. A pilot study of etanercept treatment for pemphigus vulgaris;Fiorentino;Arch Dermatol,2011